This Key Event Relationship is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.

Relationship: 2845

Title

A descriptive phrase which clearly defines the two KEs being considered and the sequential relationship between them (i.e., which is upstream, and which is downstream). More help

Bone Remodeling leads to Bone Loss

Upstream event
The causing Key Event (KE) in a Key Event Relationship (KER). More help
Downstream event
The responding Key Event (KE) in a Key Event Relationship (KER). More help

Key Event Relationship Overview

The utility of AOPs for regulatory application is defined, to a large extent, by the confidence and precision with which they facilitate extrapolation of data measured at low levels of biological organisation to predicted outcomes at higher levels of organisation and the extent to which they can link biological effect measurements to their specific causes.Within the AOP framework, the predictive relationships that facilitate extrapolation are represented by the KERs. Consequently, the overall WoE for an AOP is a reflection in part, of the level of confidence in the underlying series of KERs it encompasses. Therefore, describing the KERs in an AOP involves assembling and organising the types of information and evidence that defines the scientific basis for inferring the probable change in, or state of, a downstream KE from the known or measured state of an upstream KE. More help

AOPs Referencing Relationship

AOP Name Adjacency Weight of Evidence Quantitative Understanding Point of Contact Author Status OECD Status
Deposition of energy leading to occurrence of bone loss adjacent Moderate Low Cataia Ives (send email) Open for citation & comment

Taxonomic Applicability

Latin or common names of a species or broader taxonomic grouping (e.g., class, order, family) that help to define the biological applicability domain of the KER.In general, this will be dictated by the more restrictive of the two KEs being linked together by the KER.  More help
Term Scientific Term Evidence Link
rhesus monkeys Macaca mulatta Moderate NCBI
human Homo sapiens Low NCBI
mouse Mus musculus High NCBI
rat Rattus norvegicus High NCBI

Sex Applicability

An indication of the the relevant sex for this KER. More help
Sex Evidence
Male High
Female High

Life Stage Applicability

An indication of the the relevant life stage(s) for this KER.  More help
Term Evidence
Adult High
Juvenile High

Key Event Relationship Description

Provides a concise overview of the information given below as well as addressing details that aren’t inherent in the description of the KEs themselves. More help

An imbalance in bone remodeling towards increased resorption of the organic and inorganic components of the bone matrix can lead to an increase in bone loss. Bone remodeling can facilitate bone loss through either stimulating the natural process of resorbing bone matrix back into the blood to facilitate vital processes, or by decreasing the deposition of replacement bone matrix, both of which result in increased bone loss. Changes to bone structure and the subsequent loss of bone results in changes to the portion of bone surface that is actively being mineralized (mineralizing surface, MS/BS). This can lead to measurable changes in the rate at which osteoid seams are mineralized (mineral apposition rate, MAR), and the amount of new bone formed per unit time in relation to the mineralizing surface (bone formation rate, BFR) (Dempster et al., 2013). The structural model index (SMI) of bone tissue, which measures the proportion of rods and plates in trabecular bone, is an important indicator of bone restructuring, with increased rod-like geometry being associated with reduced bone strength (Shahnazari et al., 2012). The resulting bone loss from dysregulated bone remodelling is characterized by deteriorated bone matrix, which is evident in measures of bone structure, including trabecular microarchitecture, cortical microarchitecture, and other measures of static bone histomorphometry, as well as measures of bone strength.

Evidence Collection Strategy

Include a description of the approach for identification and assembly of the evidence base for the KER. For evidence identification, include, for example, a description of the sources and dates of information consulted including expert knowledge, databases searched and associated search terms/strings.  Include also a description of study screening criteria and methodology, study quality assessment considerations, the data extraction strategy and links to any repositories/databases of relevant references.Tabular summaries and links to relevant supporting documentation are encouraged, wherever possible. More help

The strategy for collating the evidence on radiation stressors to support the relationship is described in Kozbenko et al 2022. Briefly, a scoping review methodology was used to prioritize studies based on a population, exposure, outcome, endpoint statement.

Evidence Map 2.0

ID Experimental Design Species Upstream Observation Downstream Observation Citation (first author, year) Notes

Evidence Map

Addresses the scientific evidence supporting KERs in an AOP setting the stage for overall assessment of the AOP. More help
Title First Author
Biological Plausibility
Dose Concordance
Temporal Concordance
Incidence Concordance
Biological Plausibility
Dose Concordance Evidence
Temporal Concordance Evidence
Incidence Concordance Evidence
Uncertainties and Inconsistencies
Addresses inconsistencies or uncertainties in the relationship including the identification of experimental details that may explain apparent deviations from the expected patterns of concordance. More help
  • Following exposure to 16 Gy of radiation, mice experienced a significant increase in trabecular BV/TV on day 8 post-irradiation relative to the non-irradiated controls, contrary to the expected outcome of decreased BV/TV (Hui et al., 2014).

Known modulating factors

This table captures specific information on the MF, its properties, how it affects the KER and respective references.1.) What is the modulating factor? Name the factor for which solid evidence exists that it influences this KER. Examples: age, sex, genotype, diet 2.) Details of this modulating factor. Specify which features of this MF are relevant for this KER. Examples: a specific age range or a specific biological age (defined by...); a specific gene mutation or variant, a specific nutrient (deficit or surplus); a sex-specific homone; a certain threshold value (e.g. serum levels of a chemical above...) 3.) Description of how this modulating factor affects this KER. Describe the provable modification of the KER (also quantitatively, if known). Examples: increase or decrease of the magnitude of effect (by a factor of...); change of the time-course of the effect (onset delay by...); alteration of the probability of the effect; increase or decrease of the sensitivity of the downstream effect (by a factor of...) 4.) Provision of supporting scientific evidence for an effect of this MF on this KER. Give a list of references.  More help

Modulating factor 

Details 

Effects on the KER

References 

Genetic 

Sclerostin knockout 

Sclerostin knockout mice blocked structural deterioration and improved bone quality after radiation. 

Chandra et al., 2017 

Drug 

Parathyroid hormone1-34 

Treatment led to a full recovery of all static bone histomorphometric parameters after irradiation. 

Chandra et al., 2014 

Drug 

ODSM 

Treatment partially recovered MAR and BV/TV in tibia. 

Wang et al., 2020 

Drug 

Antagomir-132 

Partially reversed MAR, BFR and BV/TV and completely reversed BMD. 

Hu et al., 2020 

Drug 

Osteoprotegerin 

Treatment reversed spaceflight-induced bone loss. 

Lloyd et al., 2015 

Genetic 

Calponin h1 knockout 

Calponin h1 knockout mice showed attenuated bone loss and no significant changes in bone remodeling markers under tail suspension. 

Yotsumoto, Takeoka, and Yokoyama, 2010 

Genetic 

Osteopontin knockout 

Osteopontin knockout mice showed no significant changes in bone loss and bone remodeling markers when exposed to a tail suspension model.

Ishijima et al., 2001 

Age 

Old age 

Lower estrogen at old age is thought to contribute to the detrimental effects of radiotherapy on bone loss in elderly patients.

Pacheco and Stock, 2013 

Domain of Applicability

A free-text section of the KER description that the developers can use to explain their rationale for the taxonomic, life stage, or sex applicability structured terms. More help

Evidence for this relationship has been demonstrated in vivo for monkeys, mice, and rats, with considerable evidence from mice and rats. The relationship has been demonstrated in vivo for both males and females, with considerable evidence for both. There is in vivo evidence in adolescent and adult animals, with considerable evidence for both.